- Drinking Water 2024 – Summary of the Chief Inspector’s report for drinking water in Wales
- Foreword
- Water supplies and testing
- Compliance with standards
- Learning from compliance failures
- Learning from events
- Consumer contacts
- Asset health
- Water safety planning and risk assessment
- Raw water
- Poly and perfluoroalkyl substances (PFAS)
- Audit programme
- Recommendations
- Enforcement
- SEMD
- NIS
- Materials in contact with drinking water (Regulation 31)
- Research publications
- Whistleblowers
- Working with stakeholders
- Annex A – Number of tests carried out by companies
- Annex B – Compliance with standards
- Annex C – Compliance failures and events
Poly and perfluoroalkyl substances (PFAS)
In August 2024, the Inspectorate updated its guidance to the industry regarding requirements to submit test results and summary risk assessment information for PFAS. Companies have continued with their targeted sampling strategy to focus on those sites which are likely to be at risk from PFAS contamination. In 2024, companies in England and Wales collectively carried out over 770,000 analyses for individual PFAS, and in total, over 1.8 million analyses have been performed since 2012, providing a significant dataset to understand the challenges in drinking water.
PFAS tiers are now applied to any PFAS chemicals of interest detected in the final or raw water. Sites are classified as:
- Tier 1 where PFAS concentrations are <0.01 µg/L.
- Tier 2 where PFAS concentrations are <0.1 µg/L.
- Tier 3 where PFAS concentrations are ≥0.1 µg/L
PFAS tiers are to be applied to all PFAS chemicals of interest identified in the parameter list (Annex C of the Information Direction) detected in final water. The latest guidance on the actions companies should be taking for the three tier levels is available in the Inspectorate’s most recent guidance – DWI_PFAS-Guidance_Mar_2025.pdf
Monitoring by water companies has highlighted a further PFAS of potential concern; 6:2 fluorotelomer sulfonamide alkylbetaine (6:2 FTAB). This compound has been added to the parameter list and companies are expected to initiate monitoring and reporting for this parameter as soon as practicable.
Companies are also expected to consider the effect of combined concentrations of the PFAS chemicals of interest identified in the parameter list. As such, the requirement to implement a prioritised mitigation methodology to progressively reduce PFAS concentrations in drinking water has been further extended to include combined PFAS on a ‘sum of’ basis. Companies have now implemented reporting for the ‘sum of PFAS’ based on the 48 named PFAS in the parameter list. Where sites fall into tier 2 or 3 for the sum of parameter these sites should be rolled into the existing site prioritisation approach based on their relative classification and an appropriate risk reduction strategy should aim to progressively reduce PFAS concentrations in drinking water. The Inspectorate’s three tier system is a risk-based system intended to prioritise the supply systems which require additional controls. The analysis targets the source water because this provides information on the hazard and what the necessary mitigation should be, be that blending, removal of the source water or treatment. During 2024, there were no samples reported in tier 3 for any treated water being supplied to consumers. In total 351 tests of raw water abstractions had results within tier 3. This helps to demonstrate that the current industry strategy of mitigating the risks from PFAS is working effectively to protect consumers. Ninety-six percent of the tests were less than the detection limit for their analytical methodology.
Table 10 Total number of tests in England including all results less than limit of detection
Tier | Raw water tests | Treated water tests | Total |
---|---|---|---|
Tier 1 | 287,840 | 413,084 | 700,924 |
Tier 2 | 28,888 | 17,223 | 46,111 |
Tier 3 | 351 | 0 | 292 |
Total | 317,079 | 430,307 | 747,386 |
Table 11 Total number of tests in Wales, not including results less than limit of detection
Tier | Raw water tests | Treated water tests | Total |
---|---|---|---|
Tier 1 | 75 | 443 | 518 |
Tier 2 | 6 | 0 | 6 |
Tier 3 | 0 | 0 | 0 |
Total | 81 | 443 | 524 |
In Wales, PFBS was the most prevalent species in raw water during 2024 which was present in 23 tests (28% of total PFAS detections above the limit of detection). In Wales, the most prevalent species in treated water was also PFBS, being present in 42% of tests with detections above LoD (216 in number). The table below sets out all the other parameters which contributed greater than 1% of detections by number of samples rather than by result for all tiers in raw water. This includes the ’sum of PFAS’ parameter. For reference a total of 329,192 tests were undertaken on raw water samples in England, and 12,113 in Wales, in order to produce these results.
Where PFAS is identified, action is taken by the companies in line with the risk prioritisation strategy. In 2024, there were no detections in Wales within tier 2 and 3 in final treated water. Dŵr Cymru Welsh Water had a detection within tier 2 from Llechryd works in April 2024, however as part of the company’s investigation, it was determined that the result was a false positive due to an error within the laboratory testing process. Actions were identified to prevent a reccurrence.
Table 12 Raw water tests Wales and England (greater than limit of detection)
Wales | Tier 1 Detections | Tier 2 Detections | Total | England | Tier 1 Detections | Tier 2 Detections | Tier 3 Detections | Total | |
---|---|---|---|---|---|---|---|---|---|
PFBS |
23 |
23 |
PFOS |
1499 |
541 |
74 | 2,114 | ||
PFBA |
18 |
1 |
19 |
PHFHxS |
1254 |
428 |
25 | 1,707 | |
PFOA |
10 |
1 |
11 |
PFOA |
1603 |
93 |
7 | 1,703 | |
PFHxA |
3 |
1 |
4 |
PFHxA |
1405 |
197 |
15 | 1,617 | |
11Cl-PF3OUdS |
3 |
3 |
PFBS |
1476 |
49 |
2 | 1,527 | ||
PFUnDA |
3 |
3 |
PFBA |
1223 |
46 | 1,269 | |||
PFDoDA |
2 |
2 |
PFPA |
821 |
200 |
15 | 1,036 | ||
PFDS |
2 |
2 |
PFHpA |
883 |
10 |
14 |
907 | ||
PFHpA |
1 |
1 |
2 |
PFecHS |
216 |
122 |
338 | ||
4:2 FTSA |
1 |
1 |
PFPS |
264 |
32 |
3 |
299 | ||
6:2 FTSA; 6:2 FTS |
1 |
1 |
FBSA |
206 |
12 |
7 |
225 | ||
8:2 FTSA |
1 |
1 |
6:2 FTAB |
189 |
29 |
3 |
221 | ||
FBSA |
1 |
1 |
6:2 FTSA; 6:2 FTS |
97 |
84 |
13 |
194 | ||
FHxSA |
1 |
1 |
PFDA |
193 |
1 |
194 | |||
FOSA |
1 |
1 |
FHxSA |
134 |
49 |
10 |
193 | ||
MeFOSE |
1 |
1 |
PFHpS |
123 |
13 |
136 | |||
PFecHS |
1 |
1 |
8:2 FTSA |
115 |
9 |
124 | |||
PFHpS |
1 |
1 |
HFPO-TA |
115 |
115 | ||||
PFNA |
1 |
1 |
PFNA |
115 |
115 | ||||
PFOS |
1 |
1 |
PFUnDA |
111 |
111 | ||||
PFPS |
1 |
1 |
EtFOSAA |
103 |
103 | ||||
Total |
75 |
6 |
81 |
MeFOSAA |
92 |
92 | |||
PFNS |
92 |
92 | |||||||
FOSA |
82 |
9 |
91 | ||||||
HFPO-DA (Gen X) |
82 |
82 | |||||||
PFDS |
81 |
81 | |||||||
PFDoDA |
79 |
79 | |||||||
PFHxDA |
78 |
78 | |||||||
PFODA |
78 |
78 | |||||||
PFTeA |
78 |
78 | |||||||
11Cl-PF3OUdS |
77 |
77 | |||||||
NFDHA |
75 |
75 | |||||||
EtFOSA |
74 |
74 | |||||||
PFTrDA |
74 |
74 | |||||||
4:2 FTSA |
72 |
72 | |||||||
MeFOSE |
72 |
72 | |||||||
PFEESA |
72 |
72 | |||||||
3:3 FTCA |
71 |
71 | |||||||
DONA |
71 |
71 | |||||||
PFDoS |
71 |
71 | |||||||
5:3 FTCA |
2 |
68 |
70 | ||||||
PFMOPrA |
70 |
70 | |||||||
PFMOBA |
69 |
69 | |||||||
PFUnDS |
69 |
69 | |||||||
7:3 FTCA |
68 |
68 | |||||||
MeFOSA |
68 |
68 | |||||||
EtFOSE |
63 |
63 | |||||||
9Cl-F3ONS |
34 |
34 | |||||||
Total | 14,059 | 1,924 |
256 | 16,239 |
Table 13 Treated water tests Wales and England (greater than limit of detection)
Wales | Tier 1 Detections | Total | England | Tier 1 Detections | Tier 2 Detections | Total | |
---|---|---|---|---|---|---|---|
PFBS |
216 |
216 |
PFBA | 2,939 |
75 | 3,014 | |
PFHxA |
47 |
47 |
PFHxA | 1,943 |
361 | 2,304 | |
PFOA |
39 |
39 |
PFOS | 1,493 |
214 | 1,707 | |
PFBA |
30 |
30 |
PFBS | 1,489 |
14 | 1,503 | |
PFOS |
24 |
24 |
PFPA | 1,058 |
384 | 1,442 | |
PFUnDA |
13 |
13 |
PHFHxS | 1,135 |
167 | 1,302 | |
PFDA |
10 |
10 |
PFOA | 1,068 |
57 | 1,125 | |
9Cl-F3ONS |
7 |
7 |
PFHpA |
698 |
698 | ||
EtFOSAA |
7 |
7 |
6:2 FTSA; 6:2 FTS |
84 |
367 |
451 | |
PFNS |
6 |
6 |
6:2 FTAB |
98 |
8 |
106 | |
6:2 FTSA; 6:2 FTS |
5 |
5 |
PFPS |
106 |
106 | ||
MeFOSAA |
5 |
5 |
PFDA |
86 |
86 | ||
PFDS |
5 |
5 |
FBSA |
70 |
70 | ||
11Cl-PF3OUdS |
3 |
3 |
FHxSA |
40 |
22 |
62 | |
FOSA |
3 |
3 |
PFHpS |
53 |
53 | ||
PFDoDA |
3 |
3 |
PFecHS |
41 |
8 |
49 | |
PFNA |
3 |
3 |
8:2 FTSA |
43 |
1 |
44 | |
PFPS |
3 |
3 |
PFNA |
36 |
36 | ||
3:3 FTCA |
2 |
2 |
NFDHA |
31 |
31 | ||
EtFOSA |
2 |
2 |
FOSA |
28 |
28 | ||
HFPO-TA |
2 |
2 |
PFUnDA |
27 |
27 | ||
PFHpA |
2 |
2 |
PFNS |
25 |
25 | ||
PFTrDA |
2 |
2 |
9Cl-F3ONS |
22 |
22 | ||
8:2 FTSA |
1 |
1 |
EtFOSAA |
14 |
14 | ||
EtFOSE |
1 |
1 |
MeFOSAA |
14 |
14 | ||
MeFOSE |
1 |
1 |
PFEESA |
14 |
14 | ||
PFUnDS |
1 |
1 |
PFDoDA |
11 |
11 | ||
Total |
443 |
443 |
PFDS |
8 |
8 | ||
PFTeA |
8 |
8 | |||||
11Cl-PF3OUdS |
7 |
7 | |||||
HFPO-TA |
5 |
5 | |||||
MeFOSE |
2 |
2 | |||||
EtFOSA |
1 |
1 | |||||
PFHxDA |
1 |
1 | |||||
PFMOBA |
1 |
1 | |||||
PFODA |
1 |
1 | |||||
PFUnDS |
1 |
1 | |||||
Total | 12,701 | 1,678 | 14,379 |